Treatment of aortocoronary vein graft lesions with membrane-covered stents: A multicenter surveillance trial

Circulation. 2000 Oct 24;102(17):2024-7. doi: 10.1161/01.cir.102.17.2024.

Abstract

Background: Stent implantation in lesions of degenerated aortocoronary vein grafts is associated with a high risk of periprocedural thrombus embolization and in-stent restenosis.

Methods and results: In a multicenter study, we followed up 109 consecutive patients (mean age 66+/-8 years, 12% female) who received polytetrafluoroethylene (PTFE) membrane-covered stents for 125 de novo stenoses in vein grafts 11+/-5 years after bypass surgery. Stent deployment was successful in all but 1 patient; 1 patient suffered from subacute stent thrombosis. Six-month cardiac mortality was 7% (8 patients), 3 patients (3%) underwent repeat bypass surgery, and 9 patients (8%) required target-lesion PTCA. Repeat angiography revealed vessel occlusions in 9% and in-stent restenosis in 8% of patients by the end of follow-up.

Conclusions: Membrane-covered stents appear to be a safe and efficient treatment strategy associated with a low incidence of restenosis and target-vessel revascularization. Compared with previous studies, the investigated device is not associated with an increase in mortality or late vessel occlusions.

Publication types

  • Clinical Trial
  • Multicenter Study

MeSH terms

  • Aged
  • Cohort Studies
  • Coronary Angiography
  • Coronary Artery Bypass*
  • Female
  • Follow-Up Studies
  • Graft Occlusion, Vascular / epidemiology
  • Graft Occlusion, Vascular / therapy*
  • Humans
  • Male
  • Membranes, Artificial
  • Polytetrafluoroethylene / metabolism
  • Stents*

Substances

  • Membranes, Artificial
  • Polytetrafluoroethylene